Narusheniya sna pri bolezni Parkinsona


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Disorders of sleep of and wakefulness are one of the important problems in the treatment of patients with Parkinson's disease. They can be caused by increased symptoms of Parkinson's disease in the evening and at night, use of antiparkinsonian agents, anxiety, depression, or use of some antidepressants, sudden withdrawal from benzodiazepines and other sedatives. In addition, a sleep disorders can be associated with the spread of the process of neurodegeneration on the various structures of the brain stem. Understanding the causes of sleep disorders allows to successfully resolve this problem.

Full Text

Restricted Access

About the authors

O. S Levin

Email: neurolev@mail.ru

E. A Lyashenko

Email: helendik@mail.ru

References

  1. Левин О.С., Амосова Н.А., Наймушина Т.В., Смоленцева И.Г. Сравнительное клинико-нейропсихологическое исследование больных болезнью Паркинсона и деменцией с тельцами Леви. Журн. неврологии и психиатрии им. Корсакова. 2004;1:37-42.
  2. Левин О.С., Федорова Н.В. Болезнь Паркинсона. 2-е изд. М., 2012. 352 с.
  3. Левин О.С. Когнитивные нарушения при болезни Паркинсона. М., 2008.
  4. Левин Я.И., Полуэктов М.Г. Сомнология и медицина сна. Избранные лекции. Глава 3 / Под ред. Я.И. Левина, М.Г. Полуэктова. М., 2013. С. 92-104.
  5. Экстрапирамидные расстройства. Руководство по диагностике и лечению / Под ред. В.Н. Штока, И.А. Ивановой-Смоленской, О.С. Левина. М., 2002 C. 233-56.
  6. Adi N., Mash D.C., Ali Y., et al. Melatonin MT1 and MT2 receptor expression in Parkinson's disease. Med, Sci, 2010;Monit 16:BR61-BR67.
  7. Albin R.L., Koeppe R.A., Chervin R.D., et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology. 2000;55:1410-12.
  8. American Academy of Sleep Medicine. International classification of sleep disorders 2nd ed.: Diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine, 2005.
  9. Boeve B., Silber M., Saper C., et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007;130:2770-88.
  10. Boeve B.F., Silber M.H., Ferman T.J. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med. 2003;4:281-84.
  11. Boeve B.F. REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurode-generative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad. Sci. 2010;1184: 15-54.
  12. Boot B.P., Boeve B.F., Roberts R.O., et al. Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study. Ann. Neurol. 2012; 71:49-56.
  13. Claassen D.O., Josephs K.A., Ahlskog J.E., et al. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology. 2010; 75(6):494-99.
  14. Cochen De Cock V., Abouda M., Leu S., et al. Is obstructive sleep apnea a problem in Parkinson's disease? Sleep Med. 2010;11 (3):247-52.
  15. Comella C., Nardine T., Diederich N., Stebbins G. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease. Neurology. 1998;51:526-29.
  16. Day J., Damsma G., Fibiger H.C. Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: an in vivo microdialysis study. Pharmacol. Biochem. Behav. 1991;38:723-29.
  17. Dowling G.A., Mastick J., Colling E., et al. Melatonin for sleep disturbances in Parkinson's disease. Sleep Med. 2005;6:459-66.
  18. Ferini-Strambi L., Di Gioia M., Castronovo V. et al. Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): Does the idiopathic form of RBD really exist? Neurology. 2004;62:41-45.
  19. Ferman T.J., Boeve B.F., Smith G.E., et al. REM sleep behavior disorder and dementia: cognitive differences when compared with AD. Neurology. 1999;52:951-57.
  20. Friedman J.H., Millman R.P. Sleep Disturbances and Parkinson's Disease. CNS Spectr 2008;13(3 Suppl 4):12-17.
  21. Gai W.P., Halliday G.M., Blumbergs P.C., et al. Substance P-containing neurons in the mesopontine tegmentum are severely affected in Parkinson's disease. Brain. 1991; 114:2253-67.
  22. Hirsch E.C., Graybiel A.M., Duyckaerts C., Javoy-Agid F. Neuronal loss in the pedun-culopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci USA. 1987;84:5976-80.
  23. Iranzo A., Fern ndez-Arcos A., Tolosa E., et al. Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients. PLoS One. 2014;9(2).
  24. Kunz D., Mahlberg R. A two-part, doubleblind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. J. Sleep Res. 2010; 19(4):591 -96.
  25. Massicotte-Marquez J., Dcary A., Gagnon J., et al. Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder. Neurology. 2008;70: 1250-57.
  26. Medeiros C.A., Carvalhedo de Bruin P.F., Lopes L.A., et al. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease: A randomized, double blind, placebo-controlled study. J. Neurol. 2007;254:459-64.
  27. Morrison A. The pathophysiology of REM-sleep behavior disorder. Sleep. 1998;21:446.
  28. Nomura T., Inoue Y., Mitani H. et al. Visual hallucinations as REM sleep behavior disorder in patients with Parkinson's disease. Mov. Disord. 2003;18:812-17.
  29. Olson E.J., Boeve B.F., Silber M.H. Rapid eye movement sleep behavior disorder: demographic, clinical and laboratory fi ndings in 93 cases. Brain. 2000;123:331-39.
  30. Onofrj M., Thomas A., D'Andreamatteo G. et al. Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up. Neurol Sci. 2002;23 Suppl 2:S91-94.
  31. Pahapill P.A., Lozano A.M. The peduncu-lopontine nucleus and Parkinson's disease. Brain. 2000;123:1767-83.
  32. Postuma R.B., Gagnon J., Vendette M., et al. Quantifying the risk of neurodegenera-tive disease in idiopathic REM sleep behavior disorder. Neurology. 2009;72(15).
  33. Postuma R.B., Gagnon J.F., Montplaisir J.Y. REM Sleep Behavior Disorder and Prodromal Neurodegeneration - Where Are We Headed? Tremor Other Hyperkinet Mov (N.-Y.), 2013;3 (a).
  34. Postuma R.B., Gagnon J.F., Tuineaig M., et al. Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal? Sleep. 2013;36(11): 1579-85 (b).
  35. Ratti P.L., Terzaghi M., Minafra B., et al. REM and NREM sleep enactment behaviors in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. Sleep Med. 2012;13(7):926-32.
  36. Ringman J.M., Simmons J.H. Treatment of REM sleep behavior disorder with done-pezil: a report of three cases. Neurology. 2000;55:870-871.
  37. Rye D.B., Bliwise D.L. Movement disorders specific to sleep and nocturnal manifestations of waking movement disorders. In: R.L.Watts, W.C.Koller (Eds). Movement disorders. NY: McGraw-Hill, 1997. P. 687-714.
  38. Schenck C., Bundlie S., Mahowald M. REM behavior disorder (RBD): Delayed emergence of parkinsonism and/or dementia in 65% of older men initially diagnosed with idiopathic RBD, and an analysis of the minimum & maxi mum tonic and/or phasic electromyographic abnormalities found during REM sleep. Sleep. 2003;26:A316.
  39. Schenck C., Mahowald M. REM sleep behavior disorder: Clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep. 2002;25:120-38.
  40. Sforza E., Krieger J., Petiau C. REM sleep behavior disorder: clinical and physiopath-ological findings. Sleep Med. Rev. 1997; 1:57-69.
  41. Shouse M., Siegel J. Pontine regulation of REM sleep components in cats: integrity of the pedunculopontine tegmentum (PPT) is important for phasic events but unnecessary for ato-nia during REM sleep. Brain Res. 1992;571: 50-63.
  42. Singhal N.K., Srivastava G., Patel D.K., Jain S.K., Singh M.P. Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse. J. Pineal. Res. 2011;50:97-109.
  43. Trotti L.M., Bliwise D.L. No increased risk of obstructive sleep apnea in Parkinson’s disease. Mov. Disord. 2010;25(13):2246-49.
  44. Turner R.S., D'Amato C.J., Chervin R.D., Blaivas M. The pathology of REM sleep behavior disorder with comorbid Lewy body dementia. Neurology. 2000;55:1730-32.
  45. Uchiyama M., Isse K., Tanaka K., et al. Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology. 1995; 45:709-712.
  46. Wing Y.K., Li S.X., Mok V., et al. Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 2012;83:470-472.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies